These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury. Patti MG; Goldberg HI; Arcerito M; Bortolasi L; Tong J; Way LW Am J Surg; 1996 Jan; 171(1):182-6. PubMed ID: 8554137 [TBL] [Abstract][Full Text] [Related]
48. [Comparative effectiveness of the antisecretory action of rabeprazole and esomeprazole in people with rapid metabolism of proton pump inhibitors]. Morozov SV; Tsodikova OM; Isakov VA; Gushchin AE; Shipulin GA Eksp Klin Gastroenterol; 2003; (6):58-63, 154. PubMed ID: 15065530 [TBL] [Abstract][Full Text] [Related]
49. The possible role of Helicobacter pylori in GERD. Falk GW Semin Gastrointest Dis; 2001 Jul; 12(3):186-95. PubMed ID: 11478751 [TBL] [Abstract][Full Text] [Related]
50. Precision GERD management for the 21st century. Triadafilopoulos G; Clarke JO; Hawn M Dis Esophagus; 2017 Sep; 30(9):1-6. PubMed ID: 28859369 [TBL] [Abstract][Full Text] [Related]
51. Patients with refractory reflux symptoms often do not have GERD. Herregods TV; Troelstra M; Weijenborg PW; Bredenoord AJ; Smout AJ Neurogastroenterol Motil; 2015 Sep; 27(9):1267-73. PubMed ID: 26088946 [TBL] [Abstract][Full Text] [Related]
52. High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin. Furuta T; Shirai N; Xiao F; Takashita M; Sugimoto M; Kajimura M; Ohashi K; Ishizaki T Hepatogastroenterology; 2003; 50(54):2274-8. PubMed ID: 14696516 [TBL] [Abstract][Full Text] [Related]
53. pH, healing rate, and symptom relief in patients with GERD. Huang JQ; Hunt RH Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580 [TBL] [Abstract][Full Text] [Related]
55. The role of gastroesophageal reflux in relation to symptom onset in patients with proton pump inhibitor-refractory nonerosive reflux disease accompanied by an underlying esophageal motor disorder. Izawa S; Funaki Y; Iida A; Tokudome K; Tamura Y; Ogasawara N; Sasaki M; Kasugai K Digestion; 2014; 89(1):61-7. PubMed ID: 24458115 [TBL] [Abstract][Full Text] [Related]
58. Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn. Viazis N; Karamanolis GP; Anastasiou J; Keyoglou A; Vlachogiannakos J; Ladas SD; Karamanolis DG Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1450-5. PubMed ID: 24047861 [TBL] [Abstract][Full Text] [Related]
59. Association of hiatal hernia and gastroesophageal reflux: correlation between presence and size of hiatal hernia and 24-hour pH monitoring of the esophagus. Ott DJ; Glauser SJ; Ledbetter MS; Chen MY; Koufman JA; Gelfand DW AJR Am J Roentgenol; 1995 Sep; 165(3):557-9. PubMed ID: 7645469 [TBL] [Abstract][Full Text] [Related]
60. Assessment of clinical severity and investigation of uncomplicated gastroesophageal reflux disease and noncardiac angina-like chest pain. Lemire S Can J Gastroenterol; 1997 Sep; 11 Suppl B():37B-40B. PubMed ID: 9347176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]